Law360 (April 22, 2019, 1:21 PM EDT) -- In February, in Athena Diagnostics v. Mayo Collaborative Services, the U.S. Court of Appeals for the Federal Circuit upheld the current understanding that if patent claims only recite conventional technical steps in applying a natural law, then those claims are patent-ineligible.
This interpretation of patent law has been a barrier to the patenting of diagnostics and personalized medicine claims. Patent applicants constantly lose on patent subject matter eligibility rejections because virtually every time a biomarker is used for detection it is considered directed to a law of nature or natural phenomenon.
In Athena, the Federal Circuit considered an appeal by Athena...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!